Live Science Plus
Latest about Viruses, Infections & Disease
High-fiber diet may 'rejuvenate' immune cells that fight cancer, study finds
A laboratory study reveals an interaction between dietary fiber and the gut microbiome that may be helpful for fighting cancer.
Science history: 'Patient zero' catches SARS, the older cousin of COVID — Nov. 16, 2002
A person came down with an atypical form of pneumonia in November 2002, but it would be two months before anyone realized it was the start of a pandemic.
Canada has lost its 'measles elimination status' — here's what that means
A large, ongoing outbreak that began in Canada in 2024 has cost the country its measles elimination status.
'Chemo brain' may stem from damage to the brain's drainage system
An early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain. This is linked to memory issues in mice.
COVID-19 mRNA vaccines can trigger the immune system to recognize and kill cancer, research finds
The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy.
A toddler accidently ate gonorrhea bacteria from a lab dish
In a bizarre medical case published in 1984, a young boy was inadvertently exposed to an STI-causing bacteria in a lab dish.
Could simple blood tests identify cancer earlier?
Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?
'The Big One' could be even worse than COVID-19. Here's what epidemiologist Michael Osterholm says we can learn from past pandemics.
The new book "The Big One" describes lessons learned from past pandemics and how they might be applied to mitigate the dangers of future outbreaks.
AI can now be used to design brand-new viruses. Can we stop it from making the next devastating bioweapon?
Scientists have used AI to design bacteriophages, or viruses that infect only bacteria. Does the prospect of designing viruses with AI pose threats to biosecurity?
HPV vaccination drives cervical cancer rates down in both vaccinated and unvaccinated people
Researchers have found that human papillomavirus (HPV) vaccines are highly effective at reducing cervical cancer-causing infections and can offer herd immunity, reinforcing previous research and highlighting the need for a global HPV vaccine rollout.
